Methods of studying telomere damage induced by quadruplex-ligand complexes (Q37992814)

26 August 2017

title

Methods of studying telomere damage induced by quadruplex-ligand complexes (English)

1 reference

26 August 2017

Angela Rizzo

1

0 references

Erica Salvati

object named as

Erica Salvati

series ordinal

2

0 references

Annamaria Biroccio

object named as

Annamaria Biroccio

series ordinal

3

0 references

publication date

4 March 2012

1 reference

26 August 2017

1 reference

26 August 2017

volume

57

1 reference

26 August 2017

issue

1

1 reference

26 August 2017

page(s)

93-99

1 reference

Normal human chromosomes have long G-rich telomeric overhangs at one end

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

Long G tails at both ends of human chromosomes suggest a C strand degradation mechanism for telomere shortening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

How telomeres are replicated

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

Replication and protection of telomeres

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

Physiological relevance of telomeric G-quadruplex formation: a potential drug target

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

G-quadruplex structures: in vivo evidence and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

Targeting the limitless replicative potential of cancer: the telomerase/telomere pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

G-quadruplex DNA: a potential target for anti-cancer drug design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

For better or worse? Telomerase inhibition and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

A DNA damage checkpoint response in telomere-initiated senescence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

DNA damage foci at dysfunctional telomeres

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

DNA ligase IV-dependent NHEJ of deprotected mammalian telomeres in G1 and G2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

Beginning to understand the end of the chromosome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

How shelterin protects mammalian telomeres

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

Actions of human telomerase beyond telomeres

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

The many faces of telomerase: emerging extratelomeric effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

Telosome, a mammalian telomere-associated complex formed by multiple telomeric proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

Structural identity of telomeric complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

The telomeric protein TRF2 binds the ATM kinase and can inhibit the ATM-dependent DNA damage response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

TRF2 Protects Human Telomeres from End-to-End Fusions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

Role of the telomeric DNA-binding protein TRF2 in the stability of human chromosome ends

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

Human telomeres contain two distinct Myb-related proteins, TRF1 and TRF2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

Pot1, the putative telomere end-binding protein in fission yeast and humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

POT1 as a terminal transducer of TRF1 telomere length control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

POT1 protects telomeres from a transient DNA damage response and determines how human chromosomes end

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

Imetelstat (GRN163L)--telomerase-based cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

Structural insights into G-quadruplexes: towards new anticancer drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

Telomere maintenance as a target for anticancer drug discovery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

Anticancer activity of CX-3543: a direct inhibitor of rRNA biogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

Human telomeric G-quadruplex: the current status of telomeric G-quadruplexes as therapeutic targets in human cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

C-11 diamino cryptolepine derivatives NSC748392, NSC748393, and NSC748394: anticancer profile and G-quadruplex stabilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

G-quadruplex ligand RHPS4 potentiates the antitumor activity of camptothecins in preclinical models of solid tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

DNA Damage Persistence as Determinant of Tumor Sensitivity to the Combination of Topo I Inhibitors and Telomere-Targeting Agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

N-cyclic bay-substituted perylene G-quadruplex ligands have selective antiproliferative effects on cancer cells and induce telomere damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

G-quadruplex interacting agents targeting the telomeric G-overhang are more than simple telomerase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

Biological activity of the G-quadruplex ligand RHPS4 (3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate) is associated with telomere capping alteration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

Telomere damage induced by the G-quadruplex ligand RHPS4 has an antitumor effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

Stabilization of quadruplex DNA perturbs telomere replication leading to the activation of an ATR-dependent ATM signaling pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

Telomeric repeat containing RNA and RNA surveillance factors at mammalian chromosome ends

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

Developmentally regulated transcription of mammalian telomeres by DNA-dependent RNA polymerase II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

DNA and RNA quadruplex ligands.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

Structural basis of telomeric RNA quadruplex--acridine ligand recognition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

Telomere states and cell fates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

TRF2 inhibition triggers apoptosis and reduces tumourigenicity of human melanoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

Cell senescence and telomere shortening induced by a new series of specific G-quadruplex DNA ligands.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

G-quadruplexes as therapeutic targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

The human TTAGGG repeat factors 1 and 2 bind to a subset of interstitial telomeric sequences and satellite repeats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

Shelterin: the protein complex that shapes and safeguards human telomeres

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

Role of ATM in the telomere response to the G-quadruplex ligand 360A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

Rad51 and DNA-PKcs are involved in the generation of specific telomere aberrations induced by the quadruplex ligand 360A that impair mitotic cell progression and lead to cell death.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

Apollo, an Artemis-related nuclease, interacts with TRF2 and protects human telomeres in S phase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

The Apollo 5' exonuclease functions together with TRF2 to protect telomeres from DNA repair

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

Mammalian telomeres resemble fragile sites and require TRF1 for efficient replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

Increased telomere fragility and fusions resulting from TRF1 deficiency lead to degenerative pathologies and increased cancer in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

TRF2 and apollo cooperate with topoisomerase 2alpha to protect human telomeres from replicative damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

ERCC1/XPF removes the 3' overhang from uncapped telomeres and represses formation of telomeric DNA-containing double minute chromosomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

Telomere strand-specific length analysis by fluorescent in situ hybridization (Q-CO-FISH)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

Semi-conservative DNA replication through telomeres requires Taz1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

Functional human telomeres are recognized as DNA damage in G2 of the cell cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

Unwinding the molecular basis of the Werner syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

Defective telomere lagging strand synthesis in cells lacking WRN helicase activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

The DNA damage machinery and homologous recombination pathway act consecutively to protect human telomeres

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.02.010

10.1016/J.YMETH.2012.02.010

7 January 2021

Identifiers

DOI

1 reference

26 August 2017

1 reference